Sevoflurane provides better haemodynamic stability than propofol during right ventricular ischaemia-reperfusion
(2020) In Interactive Cardiovascular and Thoracic Surgery 30(1). p.129-135- Abstract
OBJECTIVES: To assess whether sevoflurane provides better haemodynamic stability than propofol in acute right ventricular (RV) ischaemia-reperfusion. METHODS: Open-chest pigs (mean ± standard deviation, 68.8 ± 4.2 kg) anaesthetized with sevoflurane (n = 6) or propofol (n = 6) underwent 60 min of RV free wall ischaemia and 150 min of reperfusion. Haemodynamic parameters and blood flow in the 3 major coronary arteries were continuously monitored. Biomarkers of cardiac ischaemia were analysed. RESULTS: Mean arterial pressure and stroke volume decreased, whereas pulmonary vascular resistance increased equally in both groups. Heart rate increased 7.5% with propofol (P < 0.05) and 17% with sevoflurane (P < 0.05). At reperfusion, left... (More)
OBJECTIVES: To assess whether sevoflurane provides better haemodynamic stability than propofol in acute right ventricular (RV) ischaemia-reperfusion. METHODS: Open-chest pigs (mean ± standard deviation, 68.8 ± 4.2 kg) anaesthetized with sevoflurane (n = 6) or propofol (n = 6) underwent 60 min of RV free wall ischaemia and 150 min of reperfusion. Haemodynamic parameters and blood flow in the 3 major coronary arteries were continuously monitored. Biomarkers of cardiac ischaemia were analysed. RESULTS: Mean arterial pressure and stroke volume decreased, whereas pulmonary vascular resistance increased equally in both groups. Heart rate increased 7.5% with propofol (P < 0.05) and 17% with sevoflurane (P < 0.05). At reperfusion, left atrial pressure and systemic vascular resistance decreased with sevoflurane. While RV stroke work (mmHg·ml) and cardiac output (l·min-1) decreased in the propofol group (4.2 ± 1.2 to 2.9 ± 1.7 and 2.65 ± 0.44 to 2.28 ± 0.56, respectively, P < 0.05 both), they recovered to baseline levels in the sevoflurane group (4.1 ± 1.5 to 4.0 ± 1.5 and 2.77 ± 0.6 to 2.6 ± 0.5, respectively, P > 0.05). Circumflex and left anterior descending coronary artery blood flow decreased in both groups. Right coronary artery blood flow (ml·min-1) decreased with propofol (38 ± 9 to 28 ± 9, P < 0.05), but not with sevoflurane (28 ± 11 to 28 ± 17, P > 0.05). Biomarkers of cardiac ischaemia increased in both groups. CONCLUSIONS: Compared to propofol, sevoflurane-anaesthetized pigs showed higher RV stroke work, cardiac output and right coronary artery blood flow during reperfusion. These findings warrant a clinical trial of sevoflurane in RV ischaemia in humans.
(Less)
- author
- Haraldsen, Pernille LU ; Cunha-Goncalves, Doris LU ; Metzsch, Carsten LU ; Algotsson, Lars LU ; Lindstedt, Sandra LU and Ingemansson, Richard LU
- organization
- publishing date
- 2020
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cardioprotection, Ischaemia–reperfusion, Propofol, Right ventricular, Sevoflurane
- in
- Interactive Cardiovascular and Thoracic Surgery
- volume
- 30
- issue
- 1
- pages
- 7 pages
- publisher
- European Association of Cardio-Thoracic Surgery
- external identifiers
-
- pmid:31580431
- scopus:85077226039
- ISSN
- 1569-9285
- DOI
- 10.1093/icvts/ivz235
- language
- English
- LU publication?
- yes
- id
- c8761b6c-ebd9-411c-a1d4-a348572837d7
- date added to LUP
- 2020-01-10 11:10:04
- date last changed
- 2024-10-02 19:35:23
@article{c8761b6c-ebd9-411c-a1d4-a348572837d7, abstract = {{<p>OBJECTIVES: To assess whether sevoflurane provides better haemodynamic stability than propofol in acute right ventricular (RV) ischaemia-reperfusion. METHODS: Open-chest pigs (mean ± standard deviation, 68.8 ± 4.2 kg) anaesthetized with sevoflurane (n = 6) or propofol (n = 6) underwent 60 min of RV free wall ischaemia and 150 min of reperfusion. Haemodynamic parameters and blood flow in the 3 major coronary arteries were continuously monitored. Biomarkers of cardiac ischaemia were analysed. RESULTS: Mean arterial pressure and stroke volume decreased, whereas pulmonary vascular resistance increased equally in both groups. Heart rate increased 7.5% with propofol (P < 0.05) and 17% with sevoflurane (P < 0.05). At reperfusion, left atrial pressure and systemic vascular resistance decreased with sevoflurane. While RV stroke work (mmHg·ml) and cardiac output (l·min-1) decreased in the propofol group (4.2 ± 1.2 to 2.9 ± 1.7 and 2.65 ± 0.44 to 2.28 ± 0.56, respectively, P < 0.05 both), they recovered to baseline levels in the sevoflurane group (4.1 ± 1.5 to 4.0 ± 1.5 and 2.77 ± 0.6 to 2.6 ± 0.5, respectively, P > 0.05). Circumflex and left anterior descending coronary artery blood flow decreased in both groups. Right coronary artery blood flow (ml·min-1) decreased with propofol (38 ± 9 to 28 ± 9, P < 0.05), but not with sevoflurane (28 ± 11 to 28 ± 17, P > 0.05). Biomarkers of cardiac ischaemia increased in both groups. CONCLUSIONS: Compared to propofol, sevoflurane-anaesthetized pigs showed higher RV stroke work, cardiac output and right coronary artery blood flow during reperfusion. These findings warrant a clinical trial of sevoflurane in RV ischaemia in humans.</p>}}, author = {{Haraldsen, Pernille and Cunha-Goncalves, Doris and Metzsch, Carsten and Algotsson, Lars and Lindstedt, Sandra and Ingemansson, Richard}}, issn = {{1569-9285}}, keywords = {{Cardioprotection; Ischaemia–reperfusion; Propofol; Right ventricular; Sevoflurane}}, language = {{eng}}, number = {{1}}, pages = {{129--135}}, publisher = {{European Association of Cardio-Thoracic Surgery}}, series = {{Interactive Cardiovascular and Thoracic Surgery}}, title = {{Sevoflurane provides better haemodynamic stability than propofol during right ventricular ischaemia-reperfusion}}, url = {{http://dx.doi.org/10.1093/icvts/ivz235}}, doi = {{10.1093/icvts/ivz235}}, volume = {{30}}, year = {{2020}}, }